1430P Frequency of PD-L1 positivity and microsatellite instability (MSI) in the DANTE trial: Perioperative atezolizumab with FLOT versus FLOT alone in patients with resectable esophagogastric adenocarcinoma. A randomized, open-label phase IIb trial of the German gastric group at the AIO and SAKK

Autor:	M. Schenk, Timo Gaiser, U. Lindig, Natsumi Irahara, Albrecht Kretzschmar, Alexander Rheinhard Siebenhuener, C. Kopp, Nils Homann, Eray Goekkurt, Sylvie Lorenzen, T.O. Götze, Claudia Pauligk, J. Riera Knorrenschild, S-E. Al-Batran, Lisa Waberer, Peter C. Thuss-Patience, R.D. Hofheinz, G.M. Haag, V. Heuer, Claus Bolling
Rok vydání:	2021
Předmět:	medicine.medical_specialty biology business.industry Microsatellite instability Hematology Perioperative medicine.disease Gastroenterology PHASE IIB TRIAL Oncology Atezolizumab PD-L1 Internal medicine biology.protein Medicine Adenocarcinoma In patient Open label business
Zdroj:	Annals of Oncology. 32:S1069-S1070
ISSN:	0923-7534
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::2359a1f832619abf799305a9d8dc3637 https://doi.org/10.1016/j.annonc.2021.08.1539 Zobrazit plný text záznamu